Group 1 - Longyang Technology announced that as of the disclosure date, its shareholder, Ningbo Longyang Yonghui Investment Management Partnership, holds approximately 7.7 million shares, accounting for 2.68% of the total share capital [2] - The shares held by the shareholder were acquired before the company's initial public offering and were released from restrictions on November 7, 2022 [2] - The company received a notice from Longyang Yonghui regarding a share reduction plan, intending to reduce up to 1.92 million shares, not exceeding 0.67% of the total share capital, within three months after the disclosure [2] Group 2 - The revenue composition of Longyang Technology for the year 2024 is projected to be 89.34% from specialty functional films and 10.66% from other businesses [3]

此外，公司副董事长杨衷核直接持有公司股份7.5万股，占总股本0.0261%；董事、副总经理、财务总监 李辰直接持有8.25万股，占总股本0.0287%；副总经理杨承翰直接持有5万股，占总股本0.0174%；副总 经理周玉波直接持有7.92万股，占总股本0.0276%。这些股份均为公司2020年限制性股票激励计划首次 授予部分第一个归属期归属股份，已于2021年12月3日上市流通 。 减持计划详情 近日，宁波长阳科技股份有限公司发布股东及董事、高管减持股份计划公告，披露了相关股东及董监高 的减持计划。 减持主体情况 截至公告披露日，长阳永汇作为公司员工持股平台，合伙人包含部分董事、监事及高管，持有公司股份 770.0583万股，占总股本2.68%，该部分股份为公司首次公开发行股票并上市前持有，已于2022年11月7 日解除限售并上市流通。 长阳永汇因自身资金需求，计划通过集中竞价、大宗交易方式减持，合计减持股份数不超192万股，即 不超过公司总股本的0.67%，减持期间为自公告披露之日起15个交易日后的3个月内，具体减持价格按 减持实施时的市场价格确定。 杨衷核、李辰、杨承翰、周玉波因个人资金需求，计划通过集中 ...

证券代码：688299 证券简称：长阳科技 公告编号：2025-036 减持计划的主要内容 近日，公司收到股东长阳永汇发来的《股份减持计划告知函》，因自身资金 需求，长阳永汇计划通过集中竞价、大宗交易的方式减持，合计减持股份数不超 过 1,920,000 股，即不超过公司总股本的 0.67%，减持期间为自本公告披露之日 起 15 个交易日后的 3 个月内实施。具体减持价格按减持实施时的市场价格确定， 但不低于公司首次公开发行股票的发行价。 1 宁波长阳科技股份有限公司 股东及董事、高管减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 股东及董监高持有股份的基本情况 截至本公告披露日，宁波长阳科技股份有限公司（以下简称"公司"）股东 宁波长阳永汇投资管理合伙企业（有限合伙）（以下简称"长阳永汇"）系公司员 工持股平台，其合伙人包括公司部分董事、监事及高管，持有公司股份为 7,700,583 股，占公司总股本比例为 2.68%。以上股份为公司首次公开发行股票并 上市前持有的股份，且已 ...

证券代码：688299 证券简称：长阳科技 公告编号：2025-035 宁波长阳科技股份有限公司 关于实施回购股份注销暨股份变动的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要提示： 公司于 2025 年 3 月 31 日、2025 年 4 月 16 日召开第四届董事会第二次会议、 第四届监事会第二次会议及 2025 年第三次临时股东大会，审议通过了《关于变 更部分回购股份用途并注销暨减少注册资本的议案》，同意将 2022 年回购方案的 回购股份 1,837,029 股和 2023 年回购方案的回购股份 1,266,993 股合计 3,104,022 股用途进行变更，由"用于员工持股计划或股权激励"变更为"用于 注销并减少注册资本"。公司已于 2025 年 4 月 17 日在上海证券交易所网站 （www.sse.com.cn）和《证券日报》披露了《关于注销部分回购股份并减少注册 资本暨通知债权人的公告》（公告编号：2025-018），自该公告披露之日起 45 日 内，公司未收到任何相关债权人要求公司提前清偿债务 ...

【DT新材料】 获悉，近日， 长阳科技 发布公告，公司拟使用自有资金人民币 29,900,000.00元 认购 宁波惠之星新材料科技股份有限公司发行的 923,409 股股份， 认购价格为每股32.38元，本次 认购投资完成后，公司将持有惠之星 1.83% 的股份。 本次对外投资，符合长阳科技在CPI领域的战略布局和业务发展需要，双方将充分发挥技术、资源和 产业链互补的优势，携手推进CPI及PET功能性膜材料等产品研发和应用，推动双方CPI及PET基膜 材料等产品在智能手机、电脑、电视等电子产品领域中进行规模化产业应用，促进关键光学薄膜的国 产化。 宁波惠之星新材料 成立于2016年，主营高端光学膜材料，是目前国内唯一可实现 CPI 及可折叠 PET 功能膜材料加工的量产 企业 。公司致力于实现高端光学 膜材料的国产替代，综合运用电子产品屏幕 防护材料设计及制造技术、精密涂布工艺等核心技术，对CPI、TAC、PET等基膜材料进行加工及复 合生产，提升膜材料物理属性，改善膜材料光学性能 ，使膜材料具备可折叠、耐腐蚀、防眩光、抗 刮擦、防爆裂、防指纹等功能。 公司 CPI 及 PET 功能性膜材料等产品已作为柔性 ...

Group 1: Company Announcements - Light Media's controlling shareholder plans to reduce its stake by no more than 29.24 million shares, accounting for up to 1% of the total share capital, to lower debt and improve financial structure [1] - Xinjiang Haoyuan intends to change its name to "Wanqing Energy" and its stock abbreviation accordingly [2] - Xunbang Intelligent plans to acquire controlling shares of Wuxi Indichip Microelectronics, focusing on the automotive chip sector [3] - Kangping Technology intends to acquire 100% of Suolu Electronics for 198 million yuan to enhance core competitiveness [4] - Shentong Express reported April revenue of 4.118 billion yuan, a year-on-year increase of 16.39% [5] - Wenzhou Hongfeng's controlling shareholder plans to reduce its stake by no more than 4.37 million shares, accounting for 1% of total share capital [8] - Changyang Technology plans to invest 29.9 million yuan in Ningbo Huizhixing New Materials [9] - Zhejiang Agricultural Holdings intends to publicly transfer 100% of its subsidiary Huadong Pharmaceutical, valued at 369 million yuan [10] - *ST Jinguang faces delisting risk due to stock price falling below 1 yuan for 10 consecutive trading days [11] - Huibo Yuntong plans to acquire 67.91% of Baode Computer to enhance its competitive edge [12] - Xinhua Group intends to change its name to "Yingxin Development" [13] - Purang Co. plans to reduce its stake by no more than 24,800 shares due to personal funding needs [14] - Xinhecheng plans to participate in a land auction for a commercial plot in Hangzhou, with a starting price of 1.037 billion yuan [15] - *ST Sailong's controlling shareholder plans to transfer 14.16% of shares, potentially changing control [16] - Gaoweida's controlling shareholder plans to reduce its stake by no more than 13.27 million shares due to funding needs [17] - Tianli Lithium Energy's shareholder plans to reduce its stake by no more than 3% [18] - Baijia Qiancheng's shareholder plans to reduce its stake by no more than 9.42 million shares [19] - United Optoelectronics is planning to issue shares to acquire Dongguan Changyi Optoelectronics [20] - Meg Intelligent plans to issue H-shares and apply for listing on the Hong Kong Stock Exchange [21] Group 2: Industry Insights - The express delivery industry shows growth, with Shentong Express and Yunda reporting revenue increases of 16.39% and 5.84% respectively in April [5][20] - The automotive chip sector is highlighted as a key investment area, with Xunbang Intelligent's acquisition of Indichip Microelectronics [3] - The energy sector is seeing name changes and strategic shifts, as seen with Xinjiang Haoyuan's rebranding to Wanqing Energy [2] - The pharmaceutical sector is undergoing restructuring, with Zhejiang Agricultural Holdings planning to divest its pharmaceutical subsidiary [10] - The technology sector is active in mergers and acquisitions, with Huibo Yuntong's acquisition of Baode Computer [12]

Investment Overview - The company intends to use its own funds of RMB 29,900,000 to subscribe for 923,409 shares of Ningbo Huizhi Star New Materials Technology Co., Ltd. (Huizhi Star) at a price of RMB 32.38 per share, resulting in a 1.83% ownership stake in Huizhi Star after the investment is completed [4][5] - The investment has been approved by the company's general manager's office and does not require further approval from the board of directors or shareholders [2][5] Company Background - Huizhi Star specializes in the research, production, and sales of optical hardening films and other functional film materials, which are essential components in electronic products such as smartphones, computers, and televisions [7] - The company aims to achieve domestic substitution of high-end optical film materials and utilizes advanced coating and manufacturing technologies to enhance the physical and optical properties of its film materials [7] Market Context - The consumer electronics industry is characterized by rapid product updates and strong innovation requirements, necessitating increased research and development investments from upstream suppliers like Huizhi Star to meet market demands [2][11] - Huizhi Star's revenue concentration is high, with 88.95% of its revenue coming from its top five customers in 2024, indicating potential risks if customer relationships or market demands change [12] Financial Metrics - As of 2024, Huizhi Star reported total assets of RMB 426.54 million, total liabilities of RMB 341.40 million, and operating income of RMB 330.53 million, with a net profit of RMB 21.45 million [6] Investment Rationale - The investment aligns with national industrial policies and industry development trends, presenting a favorable market outlook [12] - The collaboration is expected to leverage technological and resource synergies to advance the research and application of CPI and PET functional film materials in the electronics sector [10]

本次认购惠之星股票事项，尚需经惠之星股东会审议通过、尚需 取得全国股转公司出具的同意定向发行的函后方可实施。本次定向发 行能否取得全国股转公司出具的同意定向发行的函尚存在不确定性， 且最终取得同意定向发行的函的时间也存在不确定性。 证券代码：688299 证券简称：长阳科技 公告编号：2025-034 宁波长阳科技股份有限公司 关于自愿披露对外投资的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 宁波长阳科技股份有限公司（以下简称"公司"）拟使用自有资金人民 币 29,900,000.00 元认购宁波惠之星新材料科技股份有限公司（以下简 称"惠之星"）发行的 923,409 股股份，认购价格为每股 32.38 元，本 次认购投资完成后，公司将持有惠之星 1.83%的股份。 根据《上海证券交易所科创板股票上市规则》《公司章程》等规定，本 次投资无需提交董事会、股东大会审议，已经公司总经理办公会审议 通过。 本次投资不构成关联交易，亦不构成《上市公司重大资产重组管理办 法》规定的重大资产重组。 相关风险提 ...

Overview - Shanghai Fosun Pharmaceutical (Group) Co., Ltd. has initiated a Phase I/III clinical trial for HLX13, a biosimilar of ipilimumab, targeting unresectable advanced hepatocellular carcinoma (HCC) patients in China [2]. HLX13 Information and Research Status - HLX13 is a biosimilar of ipilimumab developed by the group, intended for treating multiple cancers including melanoma, renal cell carcinoma, colorectal cancer, HCC, non-small cell lung cancer, malignant pleural mesothelioma, and esophageal squamous cell carcinoma [3]. - As of April 2025, the group has invested approximately RMB 104 million (about $15 million) in the development of HLX13 [3]. - According to IQVIA MIDASTM data, global sales of ipilimumab formulations are projected to reach approximately $2.873 billion in 2024 [3].

随后，专家团队现场考察了已建成的应用示范线，肯定了该项目在"产学研用"协同创新中的示范效应， 同时降低了对石油基资源的依赖，符合绿色制造与可持续发展的未来趋势，一致同意通过应用示范现场 鉴定。 鉴定会的顺利举行，标志着长阳科技该项目已从技术研发向商业化应用迈出了关键一步。长阳科技相关 人士称，作为项目的参与方之一，公司将继续发挥多年来在光学膜材料领域深厚的技术积淀，加速生物 基材料在功能膜领域的研发与应用，助力我国从"材料大国"向"材料强国"迈进。 本报讯(记者吴奕萱)5月12日，由中国科学院宁波材料所牵头、宁波长阳科技股份有限公司(以下简称"长 阳科技")参与的2021年度国家重点研发计划"低成本高性能生物基聚酯和聚碳酸酯的制备与产业化"项目 课题五"低成本CBDO(一种有机聚合物单体)及高Tg(共聚酯薄膜玻璃化转变温度)、高抗冲击透明聚酯产 业化示范与应用"任务——高Tg、抗冲击透明共聚酯功能膜和容器应用示范的现场鉴定会在长阳尖端材 料研究院举行。来自宁波大学、浙大宁波理工学院、激智科技（300566）等科研单位的专家评审团，对 项目成果进行了专业评审。 鉴定会上，长阳科技副总经理、研究院院长周玉波博士作 ...